|
20.12.2024 17:00:00
|
Result of AGM
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Result of DXS AGM 2024
The Board of DXS International plc ("the Company” or "DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's annual general meeting ("AGM") held yesterday were duly passed.
All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.
| Resolution | Votes for * | % | Votes against | % | Votes withheld ** |
| Resolution 1 | 13,664,949 | 100.00% | 0 | 0.00% | 0 |
| Resolution 2 | 13,664,949 | 100.00% | 0 | 0.00% | 0 |
| Resolution 3 | 13,657,059 | 99.94% | 5,000 | 0.04% | 2,890 |
| Resolution 4 | 13,659,949 | 99.96% | 5,000 | 0.04% | 0 |
| Resolution 5 | 13,609,949 | 99.60% | 55,000 | 0.40% | 0 |
| Resolution 6 | 13,659,949 | 99.96% | 5,000 | 0.04% | 0 |
* Includes discretionary votes
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions
During the AGM, the Company's CEO, David Immelman, provided an update on DXS’s progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php No new information was provided in this presentation.
The Directors of DXS International plc accept responsibility for this announcement.
Contacts:
| David Immelman DXS International plc www.dxs-systems.com | 01252 719800 |
| AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce | 020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.
Analysen zu DXS International PLC Registered Shs
3 Knaller-Aktien im BX Musterportfolio: FISERV, Nasdaq Inc & Manhattan Associates mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Fiserv
✅ Nasdaq Inc
✅ Manhattan Associates
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| DXS International PLC Registered Shs | 0.03 | -1.85% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI legt zu -- DAX mit Rekord über 22'500 Zählern -- Asiens Börsen letztlich uneinsDer heimische Aktienmarkt präsentiert sich am Donnerstag stärker. Der deutsche Leitindex legt ebenfalls zu. Die asiatischen Börsen fanden am Donnerstag keine gemeinsame Richtung.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |